India Crosses Historic Milestone of 1 Cr HPV Vaccine Doses in Record Time
Free, safe and voluntary single-dose HPV vaccination, with parental consent, being provided to 14-year-old girls at designated government health facilities nationwide
UdaipurTimes, Nov 21, 2026 - India has achieved a major milestone in its efforts to prevent cervical cancer, with more than 1 crore doses of the Human Papillomavirus (HPV) vaccine administered under the National HPV Vaccination Campaign in less than nine months of its launch. The achievement marks a significant step towards protecting adolescent girls against HPV infections that can cause cervical cancer and reflects the growing reach of preventive healthcare services across the country.
Cervical cancer remains a significant public health concern and an important cause of cancer-related illness and mortality among women. Persistent infection with certain high-risk types of Human Papillomavirus is responsible for the vast majority of cervical cancer cases.
Launched by Prime Minister Narendra Modi in February 2026, the nationwide campaign provides free, safe and voluntary single-dose HPV vaccination, with parental consent, to 14-year-old girls at government health facilities. HPV vaccination is among the most effective preventive interventions available to reduce the risk of HPV infections. By providing vaccination to girls at the age of 14 years, the campaign seeks to offer protection well before potential exposure to HPV, thereby contributing to the long-term prevention of cervical cancer.
All vaccination sessions are conducted at designated Government health facilities under the direct supervision of trained Medical Officers. Vaccination sites are linked to 24×7 healthcare centres to facilitate prompt assessment, monitoring and management of any rare Adverse Events Following Immunisation (AEFI).
The campaign has achieved nearly 87% cumulative coverage against the identified annual target cohort of approximately 1.2 crore girls, based on the Registrar General of India (RGI) 2021 population estimates.
States and Union Territories have demonstrated sustained progress in expanding HPV vaccination coverage, with several achieving high levels of coverage of their respective identified target populations.
Six States — Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar — have achieved 100% coverage of their identified target populations under the campaign.
Among other high-performing States, Assam has recorded 95.63% coverage, followed by Telangana (95.28%), Karnataka (93.16%) and Uttarakhand (90.17%).
Chhattisgarh (86.21%) and Rajasthan (85.23%) have crossed the 80% coverage mark, while Kerala (77.02%), Tamil Nadu (76.12%), Odisha (74.90%) and the Union Territory of Dadra and Nagar Haveli and Daman and Diu (72.99%) have achieved more than 70% coverage.
In terms of absolute numbers, Uttar Pradesh leads the country with more than 29.33 lakh 14-year-old girls vaccinated, followed by Bihar with over 13.70 lakh and Gujarat with over 7.75 lakh girls vaccinated.
The National HPV Vaccination Campaign is supported by extensive global scientific evidence on the safety and effectiveness of HPV vaccines. More than 800 million HPV vaccine doses have been administered worldwide, while nearly two decades of scientific research and real-world experience have demonstrated strong protection against vaccine-targeted HPV infections and associated precancerous conditions.